Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN
Membranoproliferative glomerulonephritis
C3-convertase
Complement factor B
Glomerulopathy
DOI:
10.1681/asn.2016030343
Publication Date:
2017-01-18T02:10:46Z
AUTHORS (15)
ABSTRACT
In C3 glomerulopathy (C3G), the alternative pathway of complement is frequently overactivated by autoantibodies that stabilize convertase C3bBb. Anti-C3b and anti-factor B (anti-FB) IgG have been reported in three patients with C3G. We screened a cohort 141 C3G Ig-associated membranoproliferative GN (Ig-MPGN) for anti-FB anti-C3b using ELISA. identified seven IgG, five IgG. Of these 15 patients, ten were diagnosed Ig-MPGN. Among those available data, 92% had nephrotic syndrome, 64% AKI, 67% documented infection. Patients negative much lower rates infection (17 [25%] one [10%] patient Ig-MPGN). After 48 months, four (26%) positive developed ESRD or died. All high plasma Bb levels, six (40%) low levels C3, nine (60%) soluble C5b9. vitro, purified from Abs selectively enhanced activity; anti-C3b/anti-FB C5 cleavage. stabilized C3bBb perturbed C3b binding to receptor 1 but did not perturb factor H. conclusion, prevalence activation similar Ig-MPGN C3G, suggesting pathogenic mechanisms. Identification underlying defect could lead improved treatment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (24)
CITATIONS (93)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....